This inventor holds 1 USPTO granted patent. Top assignee: Shanghai Institute of Pharmaceutical Industry. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Zhenhua Shi: Innovator in Pharmaceutical Chemistry
Introduction
Zhenhua Shi is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on quinoline compounds. His research focuses on developing effective treatments for hyperlipidemia-related diseases.
Latest Patents
Zhenhua Shi holds a patent for a quinoline compound and its pharmaceutical composition, preparation method, and uses. The invention discloses a quinoline compound represented by a specific formula, where various elements and groups are defined. This compound is designed to inhibit HMG-CoA reductase, which is crucial for treating diseases effectively. The patent highlights the compound's excellent lipid reduction effect in vivo, making it a valuable asset in the pharmaceutical industry.
Career Highlights
Zhenhua Shi is affiliated with the Shanghai Institute of Pharmaceutical Industry, where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in medicine, particularly in the treatment of conditions related to lipid metabolism.
Collaborations
Zhenhua Shi has collaborated with notable colleagues, including Zhengyan Cai and Weicheng Zhou. These partnerships have contributed to the advancement of his research and the successful development of innovative pharmaceutical solutions.
Conclusion
Zhenhua Shi's contributions to pharmaceutical chemistry, particularly through his patent on quinoline compounds, demonstrate his commitment to advancing medical science. His work holds promise for improving treatments for hyperlipidemia-related diseases and showcases the importance of innovation in the pharmaceutical industry.